Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|4|500-509

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.4, 2015-04, pp. : 500-509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa––carbidopa intestinal gel for treatment of advanced Parkinson’’s disease

By Fernandez H.H.   Odin P.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 907-919

Informa Healthcare

Access to resources Recommend Favorite

Suicide in Parkinson's Disease Patients Treated With Levodopa‐Carbidopa Intestinal Gel

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1434-1435

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to letter: Suicide in Parkinson's disease patients treated with levodopa‐carbidopa Intestinal Gel

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1435-1436

John Wiley & Sons Inc

Access to resources Recommend Favorite

Initiating intrajejunal infusion of levodopa/carbidopa intestinal gel: An outpatient model

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 598-599

John Wiley & Sons Inc

Access to resources Recommend Favorite

Levodopa‐carbidopa intestinal gel therapy after deep brain stimulation

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 334-335

John Wiley & Sons Inc

Access to resources Recommend Favorite